These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38012299)

  • 1. Looking ahead: ethical and social challenges of somatic gene therapy for sickle cell disease in Africa.
    Munung NS; Nnodu OE; Moru PO; Kalu AA; Impouma B; Treadwell MJ; Wonkam A
    Gene Ther; 2024 May; 31(5-6):202-208. PubMed ID: 38012299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Meaning of Informed Consent: Genome Editing Clinical Trials for Sickle Cell Disease.
    Desine S; Hollister BM; Abdallah KE; Persaud A; Hull SC; Bonham VL
    AJOB Empir Bioeth; 2020; 11(4):195-207. PubMed ID: 33044907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridging the Access Gap for Comprehensive Sickle Cell Disease Management Across Sub-Saharan Africa: Learnings for Other Global Health Interventions?
    Hegemann L; Narasimhan V; Marfo K; Kuma-Aboagye P; Ofori-Acquah S; Odame I
    Ann Glob Health; 2023; 89(1):76. PubMed ID: 38025926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caring for Africa's sickle cell children: will we rise to the challenge?
    Oron AP; Chao DL; Ezeanolue EE; Ezenwa LN; Piel FB; Ojogun OT; Uyoga S; Williams TN; Nnodu OE
    BMC Med; 2020 Apr; 18(1):92. PubMed ID: 32340612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing a global agenda for sickle cell disease: report of an international symposium and workshop in Cotonou, Republic of Benin.
    Odame I
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S571-5. PubMed ID: 20331960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Sickle Cell Disease Ontology: Enabling Collaborative Research and Co-Designing of New Planetary Health Applications.
    Nembaware V; Mazandu GK; Hotchkiss J; Safari Serufuri JM; Kent J; Kengne AP; Anie K; Munung NS; Bukini D; Bitoungui VJN; Munube D; Chirwa U; Chunda-Liyoka C; Jonathan A; Flor-Park MV; Esoh KK; Jonas M; Mnika K; Oosterwyk C; Masamu U; Morrice J; Uwineza A; Nguweneza A; Banda K; Nyanor I; Adjei DN; Siebu NE; Nkanyemka M; Kuona P; Tayo BO; Campbell A; Oron AP; Nnodu OE; Painstil V; Makani J; Mulder N; Wonkam A
    OMICS; 2020 Oct; 24(10):559-567. PubMed ID: 33021900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curative options for sickle cell disease in Africa: Approach in Tanzania.
    Makani J;
    Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):66-70. PubMed ID: 32201150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing a Multi-Country Sickle Cell Disease Registry in Africa: Ethical Considerations.
    Munung NS; Nembaware V; de Vries J; Bukini D; Tluway F; Treadwell M; Sangeda RZ; Mazandu G; Jonas M; Paintsil V; Nnodu OE; Balandya E; Makani J; Wonkam A
    Front Genet; 2019; 10():943. PubMed ID: 31649726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyurea for children with sickle cell disease in sub-Saharan Africa: A summary of the evidence, opportunities, and challenges.
    Dexter D; McGann PT
    Pharmacotherapy; 2023 May; 43(5):430-441. PubMed ID: 36906823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation science research for the scale-up of evidence-based interventions for sickle cell disease in africa: a commentary.
    Gyamfi J; Ojo T; Iwelunmor J; Ogedegbe G; Ryan N; Diawara A; Nnodu O; Wonkam A; Royal C; Peprah E
    Global Health; 2021 Feb; 17(1):20. PubMed ID: 33596947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle cell disease in sub-Saharan Africa: stakes and strategies for control of the disease.
    Diallo DA; Guindo A
    Curr Opin Hematol; 2014 May; 21(3):210-4. PubMed ID: 24613937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to improve healthcare services for patients with sickle cell disease in Nigeria: The perspectives of stakeholders.
    Isa H; Okocha E; Adegoke SA; Nnebe-Agumadu U; Kuliya-Gwarzo A; Sopekan A; Ofakunrin AO; Ugwu N; Hassan AA; Ohiaeri C; Madu A; Diaku-Akinwumi I; Ekwem L; Dogara LG; Okoh D; Jasini J; Girei A; Ekwere T; Okolo A; Kangiwa U; Lawson J; Chianumba R; Brown B; Akinola N; Nwegbu M; Nnodu O
    Front Genet; 2023; 14():1052444. PubMed ID: 36816043
    [No Abstract]   [Full Text] [Related]  

  • 15. Perspectives of Sickle Cell Disease Stakeholders on Heritable Genome Editing.
    Hollister BM; Gatter MC; Abdallah KE; Armsby AJ; Buscetta AJ; Byeon YJJ; Cooper KE; Desine S; Persaud A; Ormond KE; Bonham VL
    CRISPR J; 2019 Dec; 2(6):441-449. PubMed ID: 31742431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives in Genetics and Sickle Cell Disease Prevention in Africa: Beyond the Preliminary Data from Cameroon.
    Wonkam A; Ngo Bitoungui VJ; Ngogang J
    Public Health Genomics; 2015; 18(4):237-41. PubMed ID: 26044545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distributional Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease in the United States.
    Goshua G; Calhoun C; Ito S; James LP; Luviano A; Krishnamurti L; Pandya A
    Ann Intern Med; 2023 Jun; 176(6):779-787. PubMed ID: 37247420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic therapies for the first molecular disease.
    Doerfler PA; Sharma A; Porter JS; Zheng Y; Tisdale JF; Weiss MJ
    J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33855970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stakeholder perspectives on ethical challenges in HIV vaccine trials in South Africa.
    Essack Z; Koen J; Barsdorf N; Slack C; Quayle M; Milford C; Lindegger G; Ranchod C; Mukuka R
    Dev World Bioeth; 2010 Apr; 10(1):11-21. PubMed ID: 19459900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caught between pity, explicit bias, and discrimination: a qualitative study on the impact of stigma on the quality of life of persons living with sickle cell disease in three African countries.
    Munung NS; Treadwell M; Kamga KK; Dennis-Antwi J; Anie K; Bukini D; Makani J; Wonkam A
    Qual Life Res; 2024 Feb; 33(2):423-432. PubMed ID: 37889387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.